A Study of Paliperidone Palmitate 6-Month Formulation

Condition:   Schizophrenia Interventions:   Drug: PP6M 700 mg eq.;   Drug: PP6M 1000 mg eq.;   Drug: PP3M 350 mg eq.;   Drug: PP3M 525 mg eq.;   Drug: PP1M;   Other: Placebo Sponsor:   Janssen Research & Development, LLC Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials